NovoCure (NVCR) Net Cash Flow (2014 - 2026)
NovoCure (NVCR) posted Net Cash Flow of $6.3 million for Q2 2026, up 206.17% sequentially from -$5.9 million in Q1 2026, and down 71.91% YoY from $22.4 million in Q2 2025.
NovoCure (NVCR) Net Cash Flow (2014 - 2026) Analysis & Trends
NovoCure has reported Net Cash Flow for 13 years, with the latest figure at $6.3 million in Q2 2026.
- Quarterly Net Cash Flow fell 71.91% year-over-year to $6.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$48.3 million (down 188.04% YoY) and the FY2025 annual result came in at -$63.1 million, up 17.3% from the prior year.
- Net Cash Flow grew to $6.3 million in Q2 2026 per NVCR's latest filing, from -$5.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $214.9 million in Q1 2024 and troughed at -$288.8 million in Q2 2024.
- A 5-year average of -$5.9 million and a median of -$3.4 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow surged 2435.48% in 2024, then plunged 949.62% in 2025.
- Over 5 years, Net Cash Flow stood at -$128.4 million in 2022, then soared by 166.89% to $85.9 million in 2023, then tumbled by 126.76% to -$23.0 million in 2024, then slumped by 949.62% to -$241.2 million in 2025, then soared by 102.61% to $6.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $6.3 million, -$5.9 million, and -$241.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 45.10 Mn |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.30 Mn |
| Jun 30, 2026 | 6.30 Mn |
| Mar 31, 2026 | -5.94 Mn |
| Mar 31, 2026 | -5.94 Mn |
| Dec 31, 2025 | -241.17 Mn |
| Dec 31, 2025 | -241.17 Mn |
| Sep 30, 2025 | 192.53 Mn |
| Sep 30, 2025 | 192.53 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Mar 31, 2025 | -36.89 Mn |
| Mar 31, 2025 | -36.89 Mn |
| Dec 31, 2024 | -22.98 Mn |
| Dec 31, 2024 | -22.98 Mn |
| Sep 30, 2024 | 20.67 Mn |
| Sep 30, 2024 | 20.67 Mn |
| Jun 30, 2024 | -288.84 Mn |
| Jun 30, 2024 | -288.84 Mn |
| Mar 31, 2024 | 214.86 Mn |
| Mar 31, 2024 | 214.86 Mn |